$9.520
-0.319 (-3.35%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CRVS Prediction & Forecast by Similar Chart Analysis
Alphio's CRVS stock price prediction model matches the current Corvus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.59 (+0.78%). The 1-week path is $9.64 (+1.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Corvus Pharmaceuticals Inc Stock?
Corvus Pharmaceuticals Inc is currently trading at $9.52, which is significantly below its 200-day simple moving average of $14.277, indicating a bearish trend. The RSI is at 29.901, suggesting that the stock is oversold, but this could also indicate continued downward pressure. The company has a forward P/E of 0, reflecting uncertainty in future earnings, and a recent 5-day change of -9.51% shows a decline in momentum. However, insider David Scott Moore's recent purchase of shares indicates some confidence in the company's future, despite ongoing losses, with a net income of -$17,959,000 in Q2 2026. Given these factors, it may be prudent to hold off on buying until clearer positive signals emerge.
CRVS stock price ended at $9.52 on Friday, after losing -3.35%
Corvus Pharmaceuticals Inc (CRVS) last closed at $9.52, losing -3.35%. These facts feed the 1-day and 1-week CRVS price prediction above.
Analyst Consensus
Corvus Pharmaceuticals Inc (CRVS): 5 buy, 1 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Corvus Pharmaceuticals Inc (CRVS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CRVS, ranked by similarity.
Seasonality analysis for CRVS
Historically the probability of a positive October return for CRVS is 100.00%. September offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CRVS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $3.76 | $4.24 | $5.14 | -55.43% |
| Nov 2026 | $3.46 | $4.05 | $4.05 | -57.48% |
| Dec 2026 | $4.37 | $5.15 | $5.78 | -45.90% |
In 2026, Corvus Pharmaceuticals Inc (CRVS) is projected to range from $3.46 to $5.78.
Corvus Pharmaceuticals Inc 2026 monthly forecast
In Oct 2026, Corvus Pharmaceuticals Inc is projected to average $4.24, with a low of $3.76 and high of $5.14.
In Nov 2026, Corvus Pharmaceuticals Inc is projected to average $4.05, with a low of $3.46 and high of $4.05.
In Dec 2026, Corvus Pharmaceuticals Inc is projected to average $5.15, with a low of $4.37 and high of $5.78.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.